A Correlational Study on Cardiopulmonary Endurance in Male Patients with New-Onset Type 2 Diabetes

References

• Martínez-Sánchez FD, Vargas-Abonce VP, Rocha-Haro A, et al. Visceral Adiposity Index is associated with Insulin Resistance, impaired Insulin Secretion, and β-cell dysfunction in subjects at risk for Type 2 Diabetes. Diabetes Epidemiol Management. 2021;2:100013. doi:10.1016/J.DEMAN.2021.100013
   Google Scholar
• Lechner K, McKenzie AL, Kränkel N, et al. High-Risk Atherosclerosis and Metabolic Phenotype: the Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation. Metab Syndr Relat Disord. 2020;18(4):176–185. doi:10.1089/met.2019.0115
   Web of Science ®Google Scholar
• Torimoto K, Okada Y, Mori H, et al. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;12(1):1. doi:10.1186/1475-2840-12-1
   Web of Science ®Google Scholar
• Uribe-Heredia G, Arroyo-Espliguero R, Viana-Llamas MC, et al. Type 2 Diabetes Mellitus, Glycated Hemoglobin Levels, and Cardiopulmonary Exercise Capacity in Patients With Ischemic Heart Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 2020;40(3):167–173. doi:10.1097/HCR.0000000000000451
   Web of Science ®Google Scholar
• Pitocco D, Fuso L, Conte EG, et al. The Diabetic Lung - A New Target Organ? Rev Diabet Stud. 2012;9(1):23–35. doi:10.1900/RDS.2012.9.23
   PubMedGoogle Scholar
• Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–725. doi:10.1016/S2213-8587(19)30084-1
   PubMed Web of Science ®Google Scholar
• Levelt E, Pavlides M, Banerjee R, et al. Ectopic and Visceral Fat Deposition inLean and Obese Patients With Type 2 Diabetes. J Am Coll Cardiol. 2016;68(1):53–63. doi:10.1016/j.jacc.2016.03.597
   PubMed Web of Science ®Google Scholar
• Herdy AH, Ritt LE, Stein R, et al. Cardiopulmonary Exercise Test: background, Applicability and Interpretation. Arq Bras Cardiol. 2016;107(5):467–481. doi:10.5935/abc.20160171
   PubMed Web of Science ®Google Scholar
• Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020;21(17):6275. doi:10.3390/ijms21176275
   PubMed Web of Science ®Google Scholar
• Patwardhan V, Khadilkar A, Chiplonkar S, et al. Dyslipidemia and Fat Distribution in Normal Weight Insulin Resistant Men. J Assoc Physicians India. 2019;67(7):26–29.
   Google Scholar
• González N, Moreno-Villegas Z, González-Bris A, et al. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):44. doi:10.1186/s12933-017-0528-4
   PubMed Web of Science ®Google Scholar
• Han M, Qin P, Li Q, et al. Chinese visceral adiposity index: a reliable indicator of visceral fat function associated with risk of type 2 diabetes. Diabetes Metab Res Rev. 2021;37(2):e3370. doi:10.1002/dmrr.3370
   PubMed Web of Science ®Google Scholar
• Tanaka S, Kanazawa I, Sugimoto T. Visceral fat accumulation is associated with increased plasma sphingosine-1-phosphate levels in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;143:146–150. doi:10.1016/j.diabres.2018.07.003
   Web of Science ®Google Scholar
• Wang YN, Tian L, Di FS. The effect of cardiopulmonary exercise test in guiding precision exercise of patients with type 2 diabetes. J Tianjin Med Univ. 2020;2(3):222–225.
   Google Scholar
• Jin L, Min G, Wei C, et al. Exercise training on chronotropic response and exercise capacity in patients with type 2 diabetes mellitus. Exp Ther Med. 2017;13(3):899–904. doi:10.3892/etm.2017.4084
   Web of Science ®Google Scholar
• Regensteiner JG. Type 2 diabetes mellitus and cardiovascular exercise performance. Rev Endocr Metab Disord. 2004;5(3):269–276.
   Web of Science ®Google Scholar
• Liu JM, Liu HJ. The basic concept of cardiopulmonary exercise test and its clinical significance. Chin J Tuberculosis Respir. 2012;35(12):954–956. doi:10.3760/cma.j.issn.1001-0939.2012.12.027
   Google Scholar
• Gürdal A, Kasikcioglu E, Yakal S, et al. Impact of diabetes and diastolic dysfunction on exercise capacity in normotensive patients without coronary artery disease. Diab Vasc Dis Res. 2015;12(3):181–188. doi:10.1177/1479164114565631
   PubMed Web of Science ®Google Scholar
• Caron J, duManoir GR, Labrecque L, et al. Impact of type 2 diabetes on cardiorespiratory function and exercise performance. Physiol Rep. 2017;5(4):e13145. doi:10.14814/phy2.13145
   PubMed Web of Science ®Google Scholar
• Chun-Wing LA, Kwok-Wing LM, Tat-Chi LG, et al. Altered exercise gas exchange as related to microalbuminuria in type 2 diabetic patients. Chest. 2004;125(4):1292–1298. doi:10.1378/chest.125.4.1292.
   Web of Science ®Google Scholar
• O’Connor E, Green S, Kiely C, et al. Differential effects of age and type 2 diabetes on dynamic vs. peak response of pulmonary oxygen uptake during exercise. J Appl Physiol. 2015;118(8):1031–1039. doi:10.1152/japplphysiol.01040.2014
   PubMed Web of Science ®Google Scholar
• Green S, Egaña M, Baldi JC, et al. Cardiovascular control during exercise in type 2 diabetes mellitus. J Diabetes Res. 2015;2015:654204. doi:10.1155/2015/654204
   PubMed Web of Science ®Google Scholar
• Yang D, Yang Y, Li Y, et al. Physical Exercise as Therapy for Type 2 Diabetes Mellitus: from Mechanism to Orientation. Ann Nutr Metab. 2019;74(4):313–321. doi:10.1159/000500110
   PubMed Web of Science ®Google Scholar
• Duvivier BM, Schaper NC, Hesselink MK, et al. Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes. Diabetologia. 2017;60(3):490–498. doi:10.1007/s00125-016-4161-7
   PubMed Web of Science ®Google Scholar
• Amanat S, Ghahri S, Dianatinasab A, et al. Exercise and Type 2 Diabetes. Adv Exp Med Biol. 2020;1228:91–105. doi:10.1007/978-981-15-1792-1_6
   PubMed Web of Science ®Google Scholar
• Lynch NA, Nicklas BJ, Berman DM, et al. Reductions in visceral fat during weight loss and walking are associated with improvements in VO(2 max). J Appl Physiol. 2001;90(1):99–104. doi:10.1152/jappl.2001.90.1.99
   Web of Science ®Google Scholar
• Shioya-Yamada M, Shimada K, Nishitani-Yokoyama M, et al. Association Between Visceral Fat Accumulation and Exercise Tolerance in Non-Obese Subjects Without Diabetes. J Clin Med Res. 2018;10(8):630–635. doi:10.14740/jocmr3403w
   Google Scholar
• Karstoft K, Winding K, Knudsen SH, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2013;36(2):228–236. doi:10.2337/dc12-0658.
   PubMed Web of Science ®Google Scholar
• Bassi D, Mendes RG, Arakelian VM, et al. Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients - a Randomized Controlled Trial. Sports Med Open. 2016;2:31. doi:10.1186/s40798-016-0052-1
   Google Scholar
• Li J, Wei D, Liu S, et al. Efficiency of an mHealth App and Chest-Wearable Remote Exercise Monitoring Intervention in Patients With Type 2 Diabetes: a Prospective, Multicenter Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021;9(2):e23338. doi:10.2196/23338
   PubMed Web of Science ®Google Scholar
• Chartrand DJ, Larose E, Poirier P, et al. Visceral adiposity and liver fat as mediators of the association between cardiorespiratory fitness and plasma glucose-insulin homeostasis. Am J Physiol Endocrinol Metab. 2020;319(3):E548–E556. doi:10.1152/ajpendo.00251.2020
   Web of Science ®Google Scholar
• Kadoglou NP, Iliadis F, Angelopoulou N, et al. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with type 2 diabetes mellitus. Diabet Med. 2008;25(3):333–340. doi:10.1111/j.1464-5491.2007.02375.x
   Web of Science ®Google Scholar
• Kadoglou NP, Iliadis F, Sailer N, et al. Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus. Metabolism. 2010;59(4):599–607. doi:10.1016/j.metabol.2009.09.002
   PubMed Web of Science ®Google Scholar
• Kurozumi A, Okada Y, Arao T, et al. Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus. Intern Med. 2016;55(21):3091–3095. doi:10.2169/internalmedicine.55.6940
   Web of Science ®Google Scholar
• Liu DF, Jia XJ, Liu XL, et al. Correlative study on cardiopulmonary endurance in male pre-diabetic patients with abdominal obesity. Hebei Med. 2021;43(11):1689–1692. doi:10.3969/j.issn.1002-7386.2021.11.021
   Google Scholar
• Bi LN, Zheng X, Qi YY, et al. The effect of obesity on the cardiopulmonary endurance of type 2 diabetic patients. Chin General Practice. 2021;24(27):3420–3423. doi:10.12114/j.issn.1007-9572.2021.00.496
   Google Scholar